#CORONAVIRUS
AstraZeneca Withdraws Swiss Application for Coronavirus Vaccine
AstraZeneca withdraws Swiss application for coronavirus vaccine
Vaccine
British pharmaceutical company AstraZeneca has withdrawn its application for approval of its coronavirus vaccine in Switzerland.
The company said on Thursday that it withdrew it’s application after after Swiss authorities indicated that it would only be cleared for use in people aged 50 and older.
AstraZeneca filed its application to Swissmedic in October 2020.
There has been regular contact between the company and the regulators since.
Swissmedic had repeatedly said that it was lacking sufficient data to approve the drug for broad use.
The country originally ordered 5.3 million doses of AstraZeneca vaccine, but has passed on 440,000 of those to a group of five developing countries while the wait for approval dragged on.
FG Exceeds 2024 Borrowing Target by N4.79tn as Revenue Shortfall Deepens Fiscal Deficit
PTI Bloody Incident: Omo-Agege Accuses APC of Orchestrating Violence to Rig 2027 Polls
Makinde Receives Two Surveillance Aircraft, Partners Air Force to Bolster Oyo Security
OBOREVWORI’S IMPOSITION BACKFIRES AS APC LEADERS, MEMBERS BOO EDE DAFINONE IN DELTA CENTRAL, BY EJIRO AWHOTU
25-year-old Woman Allegedly Cuts Off Boyfriend’s Manhood After Learning He Wanted to Marry Another Woman
Sowore Drops Bid to Summon DSS Boss as AGF Challenges Subpoena in Defamation Trial
“DSS Mistook a Cat for Me” — Sunday Igboho Recounts Dramatic Escape During 2021 Raid
BREAKING: Appeal Court Voids Order Deregistering ADC, Four Other Political Parties
Atiku Condemns Kaduna Massacre, Says Nigerians Need Security, Not Promises
Oshiomhole Backs ‘Shoot Armed Criminals on Sight’, Says Insecurity Biggest Threat to Tinubu’s Re-election
Why Okowa Says Tinubu Deserves a Second Term to Solidify Nigeria’s Progress
US Warns Nigerians: Visa Expiry Date Does Not Determine How Long You Can Stay
We Have the Right to Deal With Illegal Migration— South Africa Fires Back at Nigeria
Fake Agency Saga: No Evidence Links Gbajabiamila to Alleged Fraud, Analyst Insists
